Lyme Disease - Drug Pipeline Landscape, 2022

Lyme disease is a tick-borne infection caused by four main species of bacteria Borrelia burgdorferi, Borrelia mayonii, Borrelia afzelii and Borrelia garinii. The disease is characterized by skin rash.

Early signs and symptoms of Lyme disease include rash and other symptoms like fever, chills, fatigue, body aches, and swollen lymph nodes. Later symptoms include erythema migrans, joint pain and other neurological problems.

To know more about Lyme Disease - Drug Pipeline , visit - https://www.globalinsightservices.com/reports/lyme-disease-drug-pipeline-landscape-2022/

Diagnosis of Lyme disease involves lab tests to identify antibodies to the bacteria can help confirm or rule out the diagnosis. They include ELISA test, Western blot test and polymerase chain reaction test.

Lyme disease is treated by using oral antibiotics and intravenous antibiotics. Doxycycline, amoxicillin, or cefuroxime antibiotics are used for treatment.

The companies active in the development of Lyme Disease Drugs include Valneva, Tarsus Pharmaceuticals, Cortene etc.

Clinical trials are ongoing for several drugs in development for Lyme disease. These drugs are in various stages of development, from early preclinical stages to late-stage clinical trials.

Get a free sample copy of this Report - https://www.globalinsightservices.com/request-sample/GIS31045

Report Highlights

Global Insight Service's, Lyme Disease - Drug Pipeline Landscape, 2022 report provides an overview of the Lyme disease pipeline drugs. This report covers detailed insights on Lyme Disease drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Lyme Disease pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Scope

The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.

Free customization available -https://www.globalinsightservices.com/request-customization/GIS31045/

Reasons to Buy

Helps to find and recognize significant therapeutics under development. Thorough understanding of pipeline structure and helps in developing corrective measures for pipeline projects.

Effective R&D strategies can be developed with deep knowledge of competitor information, analysis, and insights.

Plan collaborations with various industry partners that have role in some or the other stage of drug development such as contract manufacturing, co-development, contract research organization and commercialization etc.

Helps to create in-licensing and out-licensing opportunities by identifying prospective partners with attractive projects to expand business potential and scope.

Buy this report - https://www.globalinsightservices.com/checkout/single_user/GIS31045

Methodology

The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.